SleepApneaDisorder/[ Press Release ] / Saint Paul, MN (Vocus) December 4, 2010/ Ask any sleep apnea patient about traveling with a traditional CPAP machine and you’ll learn that real hurdles exist: they’re bulky and difficult to pack; depend on a reliable power source, preventing most from traveling to remote destinations; and require advance planning when traveling overseas.

Transcend, a new sleep apnea therapy system soon to be released for sale direct to consumers, overcomes the burdens faced by travelers with sleep apnea. In fact, its unique design—which is lightweight, compact and durable—was conceived to meet the needs of the sleep apnea patient who is on the go and enjoys traveling.

By putting the lifestyle and comfort of sleep apnea patients first, Transcend is emerging as the missing link in the evolution of sleep apnea therapy to truly open new vistas for patients. Soon the freedom to sleep anywhere—in a tent, on a sailboat, or in a truck sleeper and wake up refreshed from a full night of therapeutic, restorative sleep—will be a reality. Read the rest of this entry

Research and Markets (http://www.researchandmarkets.com/research/635732/respiratory_care_e) has announced the addition of the “Respiratory Care Equipment & Supplies – Global Strategic Business Report” report to their offering.

This report analyzes the worldwide markets for Respiratory Care Equipment & Supplies in US$ Million by the following product segments – Pulmonary Function Testing Equipment, Spirometers, Sleep Apnea Diagnostic Devices, Ventilators, Humidifiers, Nebulizers, CPAP/Bi-level Devices, Oxygen Equipment, Manual Resuscitators, and Masks, Circuits & Disposables. Read the rest of this entry

UVa Health System, Pulmonary and Critical Care Department seeks healthy children, adolescents, and young adults ages 5 to 20, with snoring and possible sleep-related obstructive breathing disorders for a research study.

The purpose of this study is to find out if an experimental portable device, called SoundTrak, can collect data about your breathing at home while you sleep, and determine whether you stop breathing during sleep (called sleep apnea). This data from the SoundTrak would then be compared to the data collected during a standard overnight sleep study at the General Clinical Research Center (GCRC) Sleep Lab. Read the rest of this entry

UVa Health System, Department of Medicine, Pulmonary Division seeks healthy men, women, children and adolescents ages 5 to 65, with snoring and possible sleep-related obstructive breathing disorders for a research study.

The purpose of the study is to determine if an experimental device for sleep monitoring can accurately tell if you are awake or asleep and how well you are sleeping. The experimental device will be compared to a sleep study done using standard sleep monitoring equipment.
The study involves 1 outpatient consent and screening visit that will last about 1 hour, and 1 overnight stay at UVa Health Systems GCRC of about 16 hours for sleep monitoring.

§ Study-related screening visit and overnight sleep test (standard test to detect the presence of sleep apnea) provided free of charge.
§ Compensation for study completion is $ 125.00
Read the rest of this entry

Reportlinker.com announces that a new market research report is available in its catalogue: “Global Sleep Apnea Diagnostic And Therapeutic Devices Industry”. 

This report analyzes the worldwide markets for Sleep Apnea Diagnostic and Therapeutic Devices in US$ Million by the following Product Segments: Diagnostic Devices (Fixed PSG, Ambulatory PSG, & Others (include Screening Devices)), and Therapeutic Devices (CPAP, Bi-Level PAP, Auto PAP, & Facial Interfaces (Masks and Humidifiers)). Read the rest of this entry

SleepApneaDisorder/ [ Press Release ]/ Agoura Hills, CA / November 18, 2010/ The new technology is here and Nationwide Medical, Inc. is making it easy to get a good night’s rest by offering the new in-home sleep test to consumers who may be at risk for Obstructive Sleep Apnea (OSA). The in-home technology has been developed as a way to diagnose OSA and enable physicians to prescribe a variety of methods available for sleep apnea treatment.

The in-home sleep test is a new medical technology that offers a variety of benefits, with the average cost a third lower than a sleep study in an overnight facility. More benefits are the ease of use and convenience of completing the test in the comfort of your own home. Read the rest of this entry

Bruderman Brothers is now providing advisory services to a Pennsylvania-based, privately-owned, JCAHO-accredited regional distributor and provider of home medical equipment and respiratory therapy products including sleep apnea testing dvices and sleep apnea therapy equipments with services.The company generates its revenues from the rental and sale of durable medical equipment (hospital beds, walkers, wheelchairs, etc.), respiratory products (oxygen concentrators, nebulizers, etc.), sleep products (items for sleep apnea, bi-level and auto-titration units), and various rehabilitation services. The company markets its products to various referral sources including physicians, assisted living facilities, personal care homes, surgical outpatient centers, hospital discharge planners, social service case managers, and pharmacies. Bruderman Brothers, Inc. is a New York-based, privately owned broker-dealer.

Research and Markets has announced the addition of the “Korea Patient Monitoring and Diagnostic Systems Market Assessment and Forecasts to 2015″ report to their offering

This report provides critical market data on the patient monitoring and diagnostics sector in Korea. It includes key market categories such as wireless hospital ambulatory monitors, multiparameter patient monitors, remote monitoring systems, blood pressure monitors, micro-electromechanical systems, cardiovascular monitoring systems, sleep apnea diagnostic systems, hearing diagnostics and glucose monitoring devices.

The report also provides market size of products in value ($mn), & volume (units) at each level of segmentation, average selling price ($) for each product type (last level of segmentation), and market shares (%) of companies at sector and category level.

State Rep. Robert Donatucci was elected to his 16th House term last week, but his career in office was tragically cut short in the early morning on Tuesday, November 9, 2010. Donatucci died in his sleep, his death caused by sleep apnea according to a doctor. Just about a week earlier, Donatucci had gone in for a sleep study, but he found the CPAP mask that he was asked to wear to be uncomfortable and did not complete the test.

“It’s unfortunate that Mr. Donatucci wasn’t tested earlier in life for sleep apnea,” says Philadelphia sleep apnea dentist, Dr. Kenneth Siegel. Dr. Siegel treats sleep apnea patients who, like State Rep. Donatucci, cannot tolerate or do not wish to undergo CPAP treatment, using oral sleep apnea appliances.

According to the American Academy of Dental Sleep Medicine, somewhere between 18 million and 20 million people in America suffer from sleep apnea, and most of them haven’t even been diagnosed. Of those who are diagnosed and are prescribed treatment with a CPAP machine (CPAP stands for continuous positive airway pressure), fewer than 50% of those patients will comply with the treatment. Read the rest of this entry

Research and Markets has announced the addition of the “Argentina Patient Monitoring and Diagnostic Systems Market Assessment and Forecasts to 2015″ report to their offering.

This report provides critical market data on the patient monitoring and diagnostics sector in Argentina. It includes key market categories- such as wireless hospital ambulatory monitors, multiparameter patient monitors, remote monitoring systems, blood pressure monitors, micro-electromechanical systems, cardiovascular monitoring systems, sleep apnea diagnostic systems, hearing diagnostics and glucose monitoring devices.

The report also provides market size of products in value ($mn), & volume (units) at each level of segmentation-, average selling price ($) for each product type (last level of segmentation), and market shares (%) of companies at sector and category level.

Research and Markets has announced the addition of the “South Africa Patient Monitoring and Diagnostic Systems Market Assessment and Forecasts to 2015″ report to their offering.

This report provides critical market data on the patient monitoring and diagnostics sector in South Africa. It includes key market categories- such as wireless hospital ambulatory monitors, multiparameter patient monitors, remote monitoring systems, blood pressure monitors, micro-electromechanical systems, cardiovascular monitoring systems, sleep apnea diagnostic systems, hearing diagnostics and glucose monitoring devices.

The report also provides market size of products in value ($mn), & volume (units) at each level of segmentation-, average selling price ($) for each product type (last level of segmentation), and market shares (%) of companies at sector and category level.

SleepQuest, Inc., the highly regarded national provider of sleep medicine services, announced today that Humana has contracted with SleepQuest to expand access to affordable Obstructive Sleep Apnea (OSA) screening, diagnostic, therapy and compliance services for the Insurer’s PPO and Medicare members.

Almost 30 million Americans are affected by OSA and approximately 20 million remain undiagnosed and at risk for more serious complications like obesity, diabetes, heart disease and stroke. As it has done with payers insuring over 200 million lives, SleepQuest will bring affordable sleep medicine to Humana physicians and patients across the country. Read the rest of this entry

SleepApneaDisorder/ [ Press Release ]/ GURNEE, IL, November 08, 2010 /– Smashed Face Syndrome can be caused by long term use of CPAP for sleep apnea. The following is excerpted from Sleep and Health Journal. 

Sleep apnea is a serious and dangerous disorder that can cause a wide variety of illness and dysfunction. CPAP is considered the Gold Standard of treatment for sleep apnea and the first line treatment for severe sleep apnea. For mild to moderate sleep apnea CPAP and Oral Appliances are considered to be the first lines of treatment. 

Numerous studies attest to the efficacy of Continuous Positive Airway Presssure (CPAP) for treating sleep apnea. Unfortunately, there are numerous articles relating to CPAP failure due to non-compliance. A recent study showed 60% of patients abandon CPAP therapy entirely and that even among patients who utilize CPAP average compliance is only 4-5 hours a night 4-5 nights a week.  Read the rest of this entry